Goldman Sachs’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.5K | Sell |
23,598
-17,118
| -42% | -$39.5K | ﹤0.01% | 4965 |
|
|
2025
Q1 | $318K | Sell |
40,716
-22,899
| -36% | -$179K | ﹤0.01% | 4475 |
|
|
2024
Q4 | $297K | Buy |
63,615
+30,606
| +93% | +$143K | ﹤0.01% | 4532 |
|
|
2024
Q3 | $178K | Buy |
33,009
+21,352
| +183% | +$115K | ﹤0.01% | 4525 |
|
|
2024
Q2 | $103K | Sell |
11,657
-75,948
| -87% | -$670K | ﹤0.01% | 4496 |
|
|
2024
Q1 | $1.03M | Buy |
+87,605
| New | +$1.03M | ﹤0.01% | 3597 |
|
|
2022
Q1 | – | Sell |
-20,053
| Closed | -$205K | – | 5815 |
|
|
2021
Q4 | $205K | Buy |
+20,053
| New | +$205K | ﹤0.01% | 4988 |
|